Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer

Title
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer
Authors
Keywords
Locally advanced non-small-cell carcinoma, Durvalumab, Tumour-infiltrated lymphocytes, and PD-L1 expression, CD8
Journal
EUROPEAN JOURNAL OF CANCER
Volume 162, Issue -, Pages 1-10
Publisher
Elsevier BV
Online
2021-12-20
DOI
10.1016/j.ejca.2021.11.013

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now